Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Net Cash Flow (2016 - 2025)

Skinvisible (SKVI) has disclosed Net Cash Flow for 16 consecutive years, with $1975.0 as the latest value for Q4 2025.

  • Quarterly Net Cash Flow fell 79.69% to $1975.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3629.0 through Dec 2025, down 119.44% year-over-year, with the annual reading at -$7716.0 for FY2025, 181.67% down from the prior year.
  • Net Cash Flow hit $1975.0 in Q4 2025 for Skinvisible, up from $525.0 in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $164543.0 in Q2 2022 to a low of -$52240.0 in Q1 2023.
  • Historically, Net Cash Flow has averaged $366.65 across 5 years, with a median of -$2330.0 in 2023.
  • Biggest five-year swings in Net Cash Flow: tumbled 539.86% in 2021 and later surged 6093.63% in 2024.
  • Year by year, Net Cash Flow stood at $16814.0 in 2021, then plummeted by 373.79% to -$46035.0 in 2022, then skyrocketed by 100.34% to $157.0 in 2023, then soared by 6093.63% to $9724.0 in 2024, then crashed by 79.69% to $1975.0 in 2025.
  • Business Quant data shows Net Cash Flow for SKVI at $1975.0 in Q4 2025, $525.0 in Q3 2025, and -$9189.0 in Q2 2025.